医学
心源性休克
心肌梗塞
应激性高血糖
内科学
心力衰竭
基里普班
不利影响
心脏病学
血糖性
心脏外科
糖尿病
经皮冠状动脉介入治疗
胰岛素
内分泌学
作者
Annu Rajpurohit,Bharat Sejoo,Rajendra Bhati,Prakash Keswani,Shrikant Sharma,Deepak Sharma,Durga Shankar Meena,Naresh Kumar Midha
出处
期刊:Cardiovascular and Hematological Disorders - Drug Targets
[Bentham Science Publishers]
日期:2021-12-01
卷期号:21 (4): 260-265
被引量:3
标识
DOI:10.2174/1871529x22666211221152546
摘要
BACKGROUND: Stress hyperglycemia is a common phenomenon in patients presenting with acute myocardial infarction (MI). We aim to evaluate the association of stress hyperglycemia at the time of hospital presentation and adverse cardiac events in myocardial infarction during the course of hospital stay. METHODS: Subjects with age ≥18 years with acute MI were recruited on hospital admission and categorized based on admission blood glucose (<180 and ≥180 mg/dl, 50 patients in each group). Both groups were compared for clinical outcomes, adverse cardiac events and mortality. We also compared the adverse cardiac outcomes based on HbA1c levels (<6% and ≥6%). RESULTS: Patients with high blood glucose on admission (stress hyperglycemia) had significant increased incidences of severe heart failure (Killip class 3 and 4), arrythmias, cardiogenic shock and mortality (p value = 0.001, 0.004, 0.044, and 0.008 respectively). There was no significant association between adverse cardiac events and HbA1c levels (heart failure 18.8% vs. 25%, p value = 0.609 and mortality 16.7% vs. 17.3%, p value = 0.856). CONCLUSIONS: Stress hyperglycemia is significantly associated with adverse clinical outcomes in patients with MI irrespective of previous diabetic history or glycemic control. Clinicians should be vigilant for admission blood glucose while treating MI patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI